myriad genetics stock analysis

The stock has a market cap of 196 billion a PE. Will Myriad Genetics Stock Go Up Next Year.

Mygn Candlestick Chart Analysis Of Myriad Genetics Inc

Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets.

. Find the latest Myriad Genetics Inc. The renowned molecular diagnostic company has a market. MYGN is currently trading in the 50-60 percentile range relative to its historical Stock Score levels.

ET by Tomi Kilgore Earnings Report Myriad Genetics Stock Is Tanking After Earnings. Ad Get Our New Stock Pick Brought To You By The Data Driven Investor. Karen Andersen Stock Strategist Leader in Genomic.

Myriad Genetics Inc. If you want to skip our analysis of the outlook on the oil prices go directly to the 5. InvestorsObserver gives Myriad Genetics Inc MYGN an overall rank of 42 which is below average.

Shares of Myriad Genetics MYGN 835 were tanking by 325 as of 1127 am. Myriad Genetics is a molecular diagnostics company that provides testing services designed to assess an individuals risk of developing a disease. Shares of Myriad Genetics stock opened at 2436 on Friday.

About the company Rewards Trading at 621 below our estimate of its fair value Earnings are forecast to grow 5685 per year Risk Analysis. Myriad Genetics stock price target cut to 14 from 17 at JP. When the transactions were called off in the previous session Stock hit the highs of 2535 after setting-off with the price of 2297.

The plunge came after the molecular diagnostics company announced disappointing fiscal 2020. Big movements in Myriad Genetics stock price on Wednesday moving 1051 between high and low Updated on Jul 20 2022 Buy or Hold candidate since 2022-07-11 Gain 3046 PDF The Myriad Genetics stock price gained 1125 on the last trading day Wednesday 20th Jul 2022 rising from 2275 to 2531. Is a genetic testing and precision medicine company.

The Score for MYGN is 55 which is 10 above its historic median score of 50 and infers lower risk than normal. The Company primarily provides testing and collaborative development of testing that is designed to assess an individualâs risk for developing the disease later in life identify a patientâs likelihood of responding to drug therapy and guide a patientâs dosing to ensure optimal. The current Myriad Genetics MYGN share price is 2198.

Shares of MYGN stock opened at 2436 on Friday. Myriad Genetics Inc. Analysts evaluate the stocks expected performance in a given time period.

Improved Outlook for Myriad Genetics Were raising our fair value estimate on the narrow-moat firm after the unveiling of a new cancer product. Over the past year the Zacks Rank 3 Hold stock has lost 161 compared with the 379 decline of the industry and 9 rise of the SP 500. 6 2020 at 636 am.

Myriad Genetics exited the second quarter of 2021 with cash and. It is currently valued at 2531. Myriad Genetics Inc.

And has now gained 3 days in a row. The company was founded. Myriad Genetics Stock Performance.

MYGN Stock Overview Myriad Genetics Inc a genetic testing and precision medicine company develops and commercializes genetic tests in the United States and internationally. Exclusive research and insights from bulls and bears. Includes annual quarterly and trailing numbers with full history and charts.

And Intermountain Precision Genomics for an offering of germline and somatic tumor testing services. - USA Stock USD 2614 094 373 As of the 1st of April Myriad Genetics secures the risk adjusted performance of 0014889 and Mean Deviation of 252. Get the Latest Recommended Stock Picks Before the Price Goes Up.

The new test report provides a customized estimate of a patients one-year risk of rapid radiographic progressionStrong Solvency. The stocks fifty day moving average price is 1983 and its two-hundred day moving average price is 2291. July 21 2022.

Find the latest Myriad Genetics Inc. Financial ratios and metrics for Myriad Genetics Inc. Has a 12-month low of 1602 and a 12-month high of 3695.

The latest indifference towards the small price fluctuations of MYRIAD GENETICS DL may encourage shareholders to take a closer look at the firm as it is trading at a share price of 00 on very low momentum in trading volume. The company executives did not add any value to MYRIAD GENETICS DL investors in MarchHowever most investors can still diversify their portfolios. For the readers interested in the stock health of Myriad Genetics Inc.

MYGN stock quote history news and other vital information to help you with your stock trading and investing. Myriad Genetics Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stocks chart. The firm produces MyRisk a 35-gene panel with the.

Companys stock value dipped to 2294 during the trading on the day. A rank of 42 means that 58 of stocks appear more favorable to our system. MYGN stock analysis from Seeking Alphas top analysts.

Has a strategic collaboration with Illumina Inc. Up 203 To Date.

Reasons To Hold On To Myriad Genetics Mygn Stock For Now